// App-Quantinova.ai

5002 : Decreased fracture rate by mandating bone protecting agents in the EORTC 1333/PEACEIII trial combining Ra223 with enzalutamide versus enzalutamide alone: An updated safety analysis.

Researchers

Presenter

  • Silke Gillessen

Principal Investigators

  • Ananya Choudhury

  • Alejo Rodriguez-Vida

  • Franco Nole

  • Enrique Gallardo Diaz

  • Thierry Andre Roumeguere

  • Gedske Daugaard

  • Yohann Loriot

  • Fred Saad

  • Raymond S. McDermott

  • Anouk Neven

  • Beatrice Fournier

  • Bertrand F. TOMBAL

Medical Centers

  • IOSI-Oncology Institute of Southern Switzerland

  • The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom

  • Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain

  • Medical Oncology Division of Urogenital and Head and Neck Tumors, European Institute of Oncology, Milan, Italy

  • Parc Tauli University Hospital, Parc Tauli Institute of Research and Innovation I3PT, Barcelona Autonomous University, Sabadell, Spain

  • Erasme Hospital, University Clinics of Brussels, Brussels, Belgium

  • NSGO & Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark

  • Department of Cancer Medicine, Gustave Roussy, Université Paris-Saclay, Villejuif, France

  • Centre Hospitalier de LUniversite de Montreal (CHUM), Montreal, QC, Canada

  • St Vincent's University Hospital, Dublin, Ireland

  • European Organisation for Research and Treatment of Cancer, Bruxels, Belgium

  • EORTC HQ, Brussels, Belgium

  • Institut de Recherche Clinique, Universite Catholique de Louvain, Brussels, Belgium

Locations

  • Switzerland

  • United Kingdom

  • Spain

  • Italy

  • Belgium

  • Denmark

  • France

  • Canada

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Enzalutamide

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT02194842

  • NCT02043678

Sponsors

  • Bayer and Astellas

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved